SAN FRANCISCO and SUZHOU, China, June 21, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and...
Read More Details
Finally We wish PressBee provided you with enough information of ( Multiple Research Results from Innovent's General Biomedicine Pipeline to be Showcased at the ADA 85th Scientific Sessions )
Also on site :
- 'General Hospital' Fans Brace for 'Slap in the Face' amid Star's Return
- Billionaire Telegram founder leaves his $14 billion fortune to the 100+ children he’s fathered—which means $132 million for each lucky Gen Alpha kid
- Sandra Oh Makes a Bold Statement About Whether She’ll Return to 'Grey’s Anatomy'